Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Guidance

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Guidance
  • News

Bakkt Tweets We Expect Net Revenue For 2023 To Be In The Range Of $62M-$72M, Which Is Up 15–30% From 2022. Note That This Represents Organic Revenue Only From Bakkt Since The Apex Crypto Acquisition Has Yet To Close

By Happy Mohamed
Today, 10:39 AM
https://twitter.com/Bakkt/status/1635688690314883088

BKKT

Read More
1 minute read
  • Earnings
  • Guidance
  • News

MoneyLion Expects Q1 FY23 Adjusted Revenue of Approximately $85M-$88M Down From $92.44M In Q4 FY22 And Consensus Of $96.3M

By Benzinga Newsdesk
Today, 10:39 AM
djusted Gross Profit margin of 58% to 62% Adjusted EBITDA of approximately ($4) to $0 million

ML

Read More
3 minute read
  • Guidance
  • News

United Airlines Holdings Sees Q1 Adjusted EPS $(0.60)-$(1.00) Vs $0.66 Est; Sees FY23 Adjusted EPS $10-$12 Vs $8.7 Est

By Happy Mohamed
Today, 10:39 AM
United Airlines Holdings, Inc. ("UAL"), the holding company whose subsidiary is United Airlines, Inc. ("United," and together with UAL, the "Company"), is providing an update regarding its

UAL

Read More
1 minute read
  • Guidance
  • News

BigBear.ai Holdings Sees FY23 Revenue $155M-$170M Vs $173.03M Est.

By Happy Mohamed
Today, 10:39 AM
2023 financial outlook provided of $155 million - $170 million in Revenue

BBAI

Read More
1 minute read
  • Guidance
  • News

Sight Sciences Sees FY23 Revenue $89M-$94M Vs $91.22M Est

By Happy Mohamed
Today, 10:39 AM
2023 Financial Guidance Sight Sciences projects revenue for the full year 2023 to range from $89 million to $94 million, which represents growth of

SGHT

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • News
  • Penny Stocks

Lightning Emotors Drops As Q4 Results Miss Expectations

By Shivani Kumaresan
Today, 10:39 AM
Lightning Emotors Inc (NYSE:ZEV) reported fourth-quarter FY22 sales growth of 2.6% year-on-year to $4.33 million, missing the consensus of $10.21…

ZEV

Read More
1 minute read
  • Guidance
  • News

Lightning eMotors Sees FY23 Revenue Of $35M- $50M; Expects Vehicle And Powertrain Sales Of 300 To 400 Units

By Benzinga Newsdesk
Today, 10:39 AM
Based on current demand and supply conditions, the Company expects: 2023 revenue to be in the range of $35 million to $50 million 2023 vehicle and powertrain sales to be in the range of 300 to 400

ZEV

Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Guidance
  • Health Care
  • News

Eagle Pharmaceuticals Sees FY23 Adjusted EPS Of $4.20-$4.53 Vs. Consensus of $4.49

By Benzinga Newsdesk
Today, 10:39 AM
Expects 2023 Adjusted EBITDA of $74.0-$80.0 million

EGRX

Read More
2 minute read
  • Cannabis
  • Earnings
  • Guidance
  • Markets
  • News
  • Penny Stocks
  • Psychedelics

MindMed Reports Full-Year 2022 Financial Results, Highlighting Anxiety & Autism Studies

By Lara Goldstein
Today, 10:39 AM
Clinical-stage biopharma company Mind Medicine (MindMed), Inc. (NASDAQ: MNMD) shared its financial results for the full year ended Dec. 31, 2022. Numbers show solid stability:

MNMD

Read More
1 minute read
  • Earnings
  • Guidance
  • News

Embraer Shares Gain After Q4 Results, Aircraft Deliveries Increase By 12.7% In FY22

By Akanksha Bakshi
Today, 10:39 AM
Embraer SA (NYSE:ERJ) reported fourth-quarter FY22 revenue of $1.992 billion, an increase of 53% year-over-year, marginally beating the consensus of…

ERJ

Posts navigation

Previous 1 2 3 … 489 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service